Search Results 461-470 of 24171 for prostate cancer
Also, we will evaluate whether the peripheral blood immune cell function is different in B/AA prostate cancer patients with metastatic disease as compared with ...
The purpose of this study is to test how well M1774 works in treating patients with prostate cancer that does not respond to treatment (refractory) and who have ...
Triptorelin is used to treat advanced prostate cancer. It is a hormone that is similar to the one normally released from the hypothalamus gland in the brain.
Prostate MRI. In the U.S., prostate cancer is the most common and second-most deadly noncutaneous cancer in men. But five-year survival rates approaching 100 ...
Prostate. Specific focus areas include clinically localized, locally advanced and high-risk prostate cancers, as well as neoadjuvant therapy for prostate cancer ...
Prostate cancer is one of the most prevalent malignancies affecting men worldwide, ranging from localized tumors to aggressive, metastatic disease (Siegel et al ...
Patients with high risk prostate cancer, defined by AUA guidelines, who elect robotic assisted radical prostatectomy with an extended pelvic lymph node ...
Define actionable vulnerabilities of drug-tolerant cancer stem cells in prostate cancer and other tumor types. Develop and study derived xenograft and ...
Radiation safety. Mayo Clinic doctors also have extensive experience treating people with carcinoid tumors, neuroendocrine tumors, prostate cancer and every ...
... Prostate Cancer. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview. Tab ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.